NRLN Action AlertClick here to urge your U.S. Representative and Senators to support bills to reduce the price of prescription drugs.
Congress Must Act to Reduce Price of Prescription Drugs
In spite of a lot of talk by members of Congress on the importance of making prescription drug prices more affordable, 30 drug companies announced at the beginning of this year price increases in the U.S. on more than 250 drugs. The price increases - the first of more to come in 2019 - ranged from 5% to 9.5% well above the nation’s rate of inflation.
Americans, especially the 58 million age 65 and older and people with disabilities on Medicare, are caught in the terrible perfect storm of prescription drug price gouging. Many of us ate taking more expensive medications while living on fixed incomes. Even with a Medicare Part D prescription plan we are paying substantial out-of-pocket costs.
Again in this new 116th Congress, the NRLN has identified bills that should be passed to make our medicines more affordable.
Please take just a few minutes to email the NRLN’s sample letter to your members of Congress. There are also options to post Facebook messages, send Tweets, make phone calls and ask an editor to write an editorial.
The bills the NRLN is supporting at this time are:
H.R. 275 and S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act, and H.R. 448 and S.99, Medicare Drug Price Negotiation Act. Passage of either Act, would direct the Secretary of Health and Human Services (HHS) to negotiate lower prices for prescription drugs under Medicare Part D.
H.R. 478 and S. 61, Safe and Affordable Drugs from Canada Act, would allow the personal importation of safe and lower priced drugs from approved pharmacies in Canada.
S. 64, Preserve Access to Affordable Generics and Biosimiliars Act, would prohibit the practice of pay-for-delay by brand name drug companies who make deals to delay or keep less expensive generic drugs off the market.
Bill Kadereit, NRLN President Bob Martina, NRLN Vice President - Grassroots